SASAKI TSUYOSHI 佐々木剛

Researcher Number	90594812
Affiliation (based on the past Project Information) *help	2012 – 2013: 岡山大学, 医学部, 客員研究員
Review Section/Research Field	Principal Investigator Orthopaedic surgery
Keywords	Principal Investigator 骨肉腫 / ウイルス療法 / テロメラーゼ

Research Projects
(1 results)
Research Products
(4 results)

Enhanced antitumor efficacy of telomerase-selective oncolytic adenobiral agent OBP-301 with chemotherapy in osteosarcoma.Principal Investigator
- Principal Investigator
  
  SASAKI TSUYOSHI
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Research Field
  
  Orthopaedic surgery
- Research Institution
  Okayama University

All 2013 2012

All Journal Article

[Journal Article] Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells.2013
- Author(s)
  Hasei, J.
- Journal Title
  
  Molecular Cancer Therapeutics
  
  Volume: 12 Issue: 3 Pages: 314-325
- DOI
  10.1158/1535-7163.mct-12-0869
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390256, KAKENHI-PROJECT-22791310, KAKENHI-PROJECT-24890132, KAKENHI-PROJECT-25293283, KAKENHI-PROJECT-25462333, KAKENHI-PROJECT-25670580
[Journal Article] A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus2012
- Author(s)
  Sasaki, T.
- Journal Title
  
  Gene Therapy
  
  Volume: (Epub ahead of print) Issue: 1 Pages: 112-118
- DOI
  10.1038/gt.2011.213
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-10J03792, KAKENHI-PROJECT-22390256, KAKENHI-PROJECT-22791310, KAKENHI-PROJECT-23591932, KAKENHI-PROJECT-24890132, KAKENHI-PROJECT-25293283, KAKENHI-PROJECT-25670580
[Journal Article] Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells.2012
- Author(s)
  Yoshida, R.
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 61 Issue: 11 Pages: 1905-1916
- DOI
  10.1007/s00262-012-1249-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390256, KAKENHI-PROJECT-22791310, KAKENHI-PROJECT-23591932, KAKENHI-PROJECT-24890132
[Journal Article] Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis2012
- Author(s)
  Tazawa, H.
- Journal Title
  
  International Journal of Cancer
  
  Volume: (Epub ahead of print) Issue: 12 Pages: 2939-2950
- DOI
  10.1002/ijc.27589
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-10J03792, KAKENHI-PROJECT-22390256, KAKENHI-PROJECT-22791310, KAKENHI-PROJECT-24890132

SASAKI TSUYOSHI 佐々木 剛

Research Projects

Research Products

Enhanced antitumor efficacy of telomerase-selective oncolytic adenobiral agent OBP-301 with chemotherapy in osteosarcoma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells.2013

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A simple detection system for adenovirus receptor expression using a telomerase-specific replication-competent adenovirus2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells.2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis2012

Author(s)

Journal Title

DOI

Data Source

SASAKI TSUYOSHI 佐々木剛